Smith & Nephew SNATS (SNN) Shares are Down -1.71%

Smith & Nephew SNATS (SNN) : During the past 4 weeks, traders have been relatively bearish on Smith & Nephew SNATS (SNN), hence the stock is down -1.53% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.87% relative to the S&P 500. The 4-week change in the price of the stock is -2.06% and the stock has fallen -1.71% in the past 1 week.

The stock has recorded a 20-day Moving Average of 0.58% and the 50-Day Moving Average is 1.52%.The 200 Day SMA reached 1.55%


Smith & Nephew SNATS (NYSE:SNN): After opening at $32.65, the stock dipped to an intraday low of $32.6 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $32.86 and the buying power remained strong till the end. The stock closed at $32.78 for the day, a gain of 1.27% for the day session. The total traded volume was 1,410,416. The stocks close on the previous trading day was $32.78.

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices, which includes orthopedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Companys Advanced Surgical Devices (ASD) segment offers products and technologies, which include orthopedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other advanced surgical devices (ASD). The Companys Advanced Wound Management (AWM) segment offers products, including Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 100 countries.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *